The Uromigos
The Uromigos
Add to My Podcasts
Episodes
About
Reviews
Promote
Episode 172: ASCO 2022: Adjuvant everolimus in renal cancer
20 minutes
Posted Jun 3, 2022 at 9:14 pm.
0:00
20:20
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
Chris Ryan describes the results of this adjuvant study.
Previous
Episode 171: Antibody drug conjugates in bladder cancer: managing adverse effects
Next
Episode 173: ASCO 2022: The Atlantis Trial - maintenance cabozantinib in bladder cancer
← See all 495 episodes of The Uromigos
